Vitamin C, intravenously, at high doses is now proven to slow the progression of COVID-19 and, in many cases, reduce symptoms dramatically and probably reduce mortality. This will continue to be a controversial subject. However, the evidence in favor of high dose vitamin C is overwhelming. In the national library of medicine, there are 948,000 publications associating vitamin C usage to respiratory condition, many of which demonstrate improved outcomes. Harvard Medical School and the Harvard School of Public health publish information of high dose IV vitamin C and show research studies that more than suggest its effectiveness against COVID-19. Some brave doctors on the frontline of COVID-19 in New York are using high dose IV on hospitalized patients because they know it provides benefits. Ask anyone who speaks against high dose vitamin C if they want take it if diagnosed and hospitalized with COVID-19. Their use of vitamin C may imply a shortage or available, but unproven pharmaceutical, or the belief that vitamin C is at least as effective without severe side effect potential.